Predictors of transient congenital hypothyroidism in children with eutopic thyroid gland

Area of Science:

• Pediatric Endocrinology
• Neonatal Screening
• Thyroid Disorders

Background:

• Congenital hypothyroidism (CH) is a leading cause of preventable intellectual disability.
• Neonatal screening programs have increased the identification of CH cases with eutopic (normally positioned) thyroid glands.
• Distinguishing between permanent CH (PCH) and transient CH (TCH) is crucial for appropriate management.

Purpose of the Study:

• To identify and evaluate predictive factors differentiating permanent from transient congenital hypothyroidism in infants with eutopic thyroid glands.
• To assess the utility of levothyroxine dosage in predicting the form of CH.

Main Methods:

• Retrospective review of 100 children diagnosed with CH and eutopic thyroid glands.
• All subjects received levothyroxine treatment and were re-evaluated after age 3.
• Analysis included initial thyroid-stimulating hormone (TSH) levels and levothyroxine doses over three years.

Main Results:

• 35% of patients had PCH, and 65% had TCH.
• Lower initial TSH levels and lower mean levothyroxine doses (µg/kg/day) at years 1, 2, and 3 were observed in TCH patients.
• A levothyroxine cutoff dose of 2.76 µg/kg/day at 3 years predicted TCH with 87.3% sensitivity and 67.6% specificity (AUC=0.769).

Conclusions:

• Levothyroxine dose requirements during treatment are predictive of TCH versus PCH in infants with eutopic thyroid glands.
• This finding aids in the long-term management strategy for congenital hypothyroidism.